Price T Rowe Associates Inc Ironwood Pharmaceuticals Inc Transaction History

Price T Rowe Associates Inc

$836 Billion
Q2 2024

A detailed history of Price T Rowe Associates Inc transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 101,448 shares of IRWD stock, worth $484,921. This represents 0.0% of its overall portfolio holdings.

Number of Shares

101,448

Previous 85,577 18.55%

Holding current value

$484,921

Previous $746,000 11.26%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$5.58 - $8.61 $88,560 - $136,649	15,871 Added 18.55%	101,448 $662,000
Q1 2024 May 15, 2024	BUY	$8.32 - $15.45 $41,541 - $77,141	4,993 Added 6.2%	85,577 $746,000
Q4 2023 Feb 14, 2024	BUY	$8.79 - $11.51 $74,512 - $97,570	8,477 Added 11.76%	80,584 $922,000
Q3 2023 Nov 14, 2023	BUY	$8.25 - $11.35 $88,786 - $122,148	10,762 Added 17.54%	72,107 $695,000
Q2 2023 Aug 14, 2023	BUY	$10.1 - $11.6 $15,665 - $17,991	1,551 Added 2.59%	61,345 $653,000
Q1 2023 May 15, 2023	SELL	$10.37 - $12.56 $341,183 - $413,236	-32,901 Reduced 35.49%	59,794 $630,000
Q4 2022 Feb 14, 2023	SELL	$9.9 - $12.43 $76,170 - $95,636	-7,694 Reduced 7.66%	92,695 $1.15 Million
Q3 2022 Nov 14, 2022	BUY	$10.14 - $12.38 $91,178 - $111,320	8,992 Added 9.84%	100,389 $1.04 Million
Q2 2022 Aug 15, 2022	SELL	$11.05 - $12.72 $1,690 - $1,946	-153 Reduced 0.17%	91,397 $1.05 Million
Q1 2022 May 16, 2022	SELL	$10.61 - $12.88 $64,370 - $78,142	-6,067 Reduced 6.22%	91,550 $1.15 Million
Q4 2021 Feb 14, 2022	SELL	$10.86 - $13.95 $266,374 - $342,165	-24,528 Reduced 20.08%	97,617 $1.14 Million
Q3 2021 Nov 15, 2021	SELL	$11.92 - $13.92 $127,544 - $148,944	-10,700 Reduced 8.05%	122,145 $1.6 Million
Q2 2021 Aug 16, 2021	SELL	$10.16 - $13.11 $183,581 - $236,884	-18,069 Reduced 11.97%	132,845 $1.71 Million
Q1 2021 May 17, 2021	SELL	$9.04 - $11.86 $200,326 - $262,817	-22,160 Reduced 12.8%	150,914 $1.69 Million
Q4 2020 Feb 16, 2021	BUY	$9.05 - $12.2 $1.57 Million - $2.11 Million	173,074 New	173,074 $1.97 Million

Others Institutions Holding IRWD

# of Institutions

244

Shares Held

168M

Call Options Held

11.2M

Put Options Held

28.5K

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $732M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Ironwood Pharmaceuticals Inc Transaction History